Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers. | Cancers (Basel) | 2022 | 35205776 | PubTator, text mining | PubMed |
| The Mysterious Actor-γδ T Lymphocytes in Chronic Lymphocytic Leukaemia (CLL). | Cells | 2022 | 35203309 | PubTator, text mining | PubMed |
| A FBXO7/EYA2-SCFFBXW7 axis promotes AXL-mediated maintenance of mesenchymal and immune evasion phenotypes of cancer cells. | Mol Cell | 2022 | 35182481 | PubTator, text mining | PubMed |
| Deciphering mechanisms of immune escape to inform immunotherapeutic strategies in multiple myeloma. | J Hematol Oncol | 2022 | 35172851 | PubTator, text mining | PubMed |
| Mapping the biogenesis of forward programmed megakaryocytes from induced pluripotent stem cells. | Sci Adv | 2022 | 35171685 | PubTator, text mining | PubMed |
| Potential role of regulatory DNA variants in modifying the risk of severe cutaneous reactions induced by aromatic anti-seizure medications. | Epilepsia | 2022 | 35170024 | PubTator, text mining | PubMed |
| Regulation of HTLV-1 transformation. | Biosci Rep | 2022 | 35169839 | PubTator, text mining | PubMed |
| Tumor-Infiltrating Lymphocytes and Their Role in Solid Tumor Progression. | Exp Suppl | 2022 | 35165861 | PubTator, text mining | PubMed |
| Tumor-Derived Exosomes in Tumor-Induced Immune Suppression. | Int J Mol Sci | 2022 | 35163380 | PubTator, text mining | PubMed |
| Recent Development in NKT-Based Immunotherapy of Glioblastoma: From Bench to Bedside. | Int J Mol Sci | 2022 | 35163235 | PubTator, text mining | PubMed |
| Cancer Immunology: From Molecular Mechanisms to Therapeutic Opportunities. | Cells | 2022 | 35159269 | PubTator, text mining | PubMed |
| Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma. | Cells | 2022 | 35159200 | PubTator, text mining | PubMed |
| Natural Killer Cell-Mediated Immunotherapy for Leukemia. | Cancers (Basel) | 2022 | 35159109 | PubTator, text mining | PubMed |
| c-Myc Targets HDAC3 to Suppress NKG2DL Expression and Innate Immune Response in N-Type SCLC through Histone Deacetylation. | Cancers (Basel) | 2022 | 35158730 | PubTator, text mining | PubMed |
| M2-phenotype tumour-associated macrophages upregulate the expression of prognostic predictors MMP14 and INHBA in pancreatic cancer. | J Cell Mol Med | 2022 | 35150061 | PubTator, text mining | PubMed |
| Modulation of the tumour microenvironment in hepatocellular carcinoma by tyrosine kinase inhibitors: from modulation to combination therapy targeting the microenvironment. | Cancer Cell Int | 2022 | 35148789 | PubTator, text mining | PubMed |
Comprehensive analysis of N6-methyladenosine regulators with the tumor immune landscape and correlation between the insulin-like growth factor 2 mRNA-binding protein 3 and programmed death ligand 1 in bladder cancer. | Cancer Cell Int | 2022 | 35148766 | PubTator, text mining | PubMed |
| Senescence and the tumor-immune landscape: Implications for cancer immunotherapy. | Semin Cancer Biol | 2022 | 35143990 | PubTator, text mining | PubMed |
| A New Trend in Cancer Treatment: The Combination of Epigenetics and Immunotherapy. | Front Immunol | 2022 | 35140720 | PubTator, text mining | PubMed |
| Role of Exosomes in Immune Microenvironment of Hepatocellular Carcinoma. | J Oncol | 2022 | 35126514 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=42